Drugs / RABACFOSADINE
RABACFOSADINE
also known as
GS 9219 · Gs-9219 succinate · GS-9219-01 · Rabacfosadina · RABACFOSADINE SUCCINATE · VDC-1101 · Vdc-1101 succinate · VDC-1101-01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00499239 | Jul 2007 → Jul 2010 | chronic lymphocytic leukemia/small lymphocytic lymphoma, plasma cell myeloma | Gilead Sciences | Terminated | No outcome recorded |
Evidence & citations 11 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RABACFOSADINE | ChEMBL registry synonym — accepted as the source's own label CHEMBL1823518 ↗ |
| Known as | GS 9219 | “GS-9219 Injection is a clear, and colorless to slightly yellow aqueous solution containing 4 mg/mL of GS 9219.” NCT00499239 ↗ |
| Known as | Gs-9219 succinate | ChEMBL registry synonym — accepted as the source's own label CHEMBL1823518 ↗ |
| Known as | GS-9219-01 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1823518 ↗ |
| Known as | Rabacfosadina | ChEMBL registry synonym — accepted as the source's own label CHEMBL1823518 ↗ |
| Known as | RABACFOSADINE SUCCINATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL1823518 ↗ |
| Known as | VDC-1101 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1823518 ↗ |
| Known as | Vdc-1101 succinate | ChEMBL registry synonym — accepted as the source's own label CHEMBL1823518 ↗ |
| Known as | VDC-1101-01 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1823518 ↗ |
| Modality | Small molecule | — CHEMBL1823518 ↗ |
| Route | Intravenous | “GS 9219 will be administered via IV infusion over 30 minutes” NCT00499239 ↗ |